Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Alkem Laboratories Ltd.
Change Company   
BSE Code 539523
ISIN Demat INE540L01014
Book Value 1041.02
NSE Code ALKEM
Dividend Yield % 0.84
Market Cap 571006.57
P/E 25.02
EPS 190.86
Face Value 2  
10-Mar-2025 Alkem Laboratories informs about analyst meet
01-Mar-2025 Alkem Laboratories informs about disclosure
11-Feb-2025 Alkem Laboratories informs about transcript of co...
07-Feb-2025 Alkem Laboratories reports 6% rise in Q3 consolid...
05-Feb-2025 Alkem Laboratories gains on launching Kojiglo ser...
04-Feb-2025 Alkem Laboratories launches Kojiglo serum in India
03-Feb-2025 Alkem Laboratories informs about disclosure
07-Jan-2025 Alkem Laboratories to sell Pithampur manufacturin...
07-Jan-2025 Alkem Laboratories informs about disclosure
18-Dec-2024 Alkem Laboratories to make equity investment in S...
18-Dec-2024 Alkem Laboratories climbs as the company to make ...
11-Dec-2024 Alkem Laboratories gains on getting nod to transf...
10-Dec-2024 Alkem Laboratories gets nod to transfer trade gen...
03-Dec-2024 Alkem Laboratories informs about investor meet
11-Oct-2024 Alkem Laboratories rises on signing licensing agr...
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.